References
Medical Products Agency’s provisions on the surveillance of medicinal products, 2006. LVFS 2006:4
van Grootheest AC, Passier JLM, van Puijenbroek EP. Direct reporting of side effects by the patient: favourable experience in the first year. Ned Tijdschr Geneeskd 2005; 149: 529–33
van Grootheest AC, Passier JLM, de Groot M. Patient reporting in the Netherlands — First results. Pharmacoepidemiology and Drug Safety 2003; 12(Suppl. 2): 30
Consumer ADR reporting — alive and well in Australia [editorial]. Uppsala Reports 2005; 31: 12–3
Wilson B. Adverse reaction reporting — 2004. Canadian Adverse Reaction Newsletter 2005; 15(2): 2
One year with ADR consumer reports. Available at the Danish Medicines Agency’s homepage. http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelID = 4710 [21th November 2005]
Patient reporting of suspected adverse drug reactions. Available at the UK Medicine Agency’s home page. http://www.mhra.gov.uk/home/idcplg?IdcService = SS_GET_PAGE&nodeId = 755 [30th June 2006]
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jansson, K., Ekbom, Y. & Sjölin-Forsberg, G. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 938 (2006). https://doi.org/10.2165/00002018-200629100-00035
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200629100-00035